NovoCure (NVCR) Times Interest Earned (2014 - 2022)

NovoCure has disclosed Times Interest Earned across 9 years of filings, most recently posting -$9.48 for Q2 2022.

• Times Interest Earned for Q2 2022 came in at -$9.48, up 27.5% year-over-year; the trailing twelve-month figure through Mar 2023 was -$66.86 (down 909.94% YoY), and the FY2021 annual result was -$5.73, down 331.66% from the prior year.
• Times Interest Earned came in at -$9.48 for Q2 2022 at NovoCure, down from -$0.47 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $3.77 in Q3 2020 to a low of -$13.08 in Q2 2021.
• The 5-year median for Times Interest Earned is -$1.79 (2018), against an average of -$2.27.
• Across the five-year window, Times Interest Earned soared 4121.37% in 2020 and sank 1318.08% in 2022, its largest moves.
• NovoCure's Times Interest Earned stood at -$4.01 in 2018, then surged by 102.19% to $0.09 in 2019, then jumped by 4121.37% to $3.7 in 2020, then slumped by 390.65% to -$10.76 in 2021, then rose by 11.85% to -$9.48 in 2022.
• The last three Times Interest Earned figures came in at -$9.48 (Q2 2022), -$0.47 (Q1 2022), and -$10.76 (Q4 2021), per Business Quant data.